Defining nosocomial transmission of Escherichia coli and antimicrobial resistance genes: a genomic surveillance study
暂无分享,去创建一个
J. Parkhill | O. Restif | S. Peacock | N. Brown | T. Gouliouris | F. Coll | Grace A. Blackwell | B. Blane | C. Ludden | Plamena Naydenova | Narender Kumar | Charles Crawley | Francesc Coll | N. Brown
[1] J. Parkhill,et al. Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance , 2020, Nature microbiology.
[2] N. Woodford,et al. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. , 2019, The Lancet. Infectious diseases.
[3] J. Parkhill,et al. A One Health Study of the Genetic Relatedness of Klebsiella pneumoniae and Their Mobile Elements in the East of England , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Steinbakk,et al. Transfer of a blaCTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses , 2018, Scientific Reports.
[5] J. Parkhill,et al. Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom , 2017, Genome Medicine.
[6] Jukka Corander,et al. Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131 , 2017, Genome research.
[7] Sergio Arredondo-Alonso,et al. On the (im)possibility of reconstructing plasmids from whole-genome short-read sequencing data , 2017, bioRxiv.
[8] Julian Parkhill,et al. ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads , 2017, bioRxiv.
[9] N. Woodford,et al. Trends in ExPEC serogroups in the UK and their significance , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[10] Andrew J. Page,et al. Roary: rapid large-scale prokaryote pan genome analysis , 2015, bioRxiv.
[11] J. R. Johnson,et al. Extensive Within-Host Diversity in Fecally Carried Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates: Implications for Transmission Analyses , 2015, Journal of Clinical Microbiology.
[12] F. Scheutz,et al. Prevalence and Characteristics of the Epidemic Multiresistant Escherichia coli ST131 Clonal Group among Extended-Spectrum Beta-Lactamase-Producing E. coli Isolates in Copenhagen, Denmark , 2013, Journal of Clinical Microbiology.
[13] Maliha Aziz,et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. , 2013, The Journal of infectious diseases.
[14] M. Bonten,et al. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. , 2012, The Journal of antimicrobial chemotherapy.
[15] Julian Parkhill,et al. Evolution of MRSA During Hospital Transmission and Intercontinental Spread , 2010, Science.
[16] E. Domann,et al. Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany , 2009, BMC infectious diseases.
[17] Y. Carmeli,et al. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.
[18] I. Petersen,et al. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. , 2007, The Journal of infection.
[19] G. Fadda,et al. Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment , 2007, Antimicrobial Agents and Chemotherapy.
[20] A. Carattoli,et al. Identification of plasmids by PCR-based replicon typing. , 2005, Journal of microbiological methods.
[21] D. Hughes,et al. Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections , 2003, Antimicrobial Agents and Chemotherapy.
[22] Daniel J Sexton,et al. Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.
[23] C. Mcnulty,et al. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) 2010 to 2014: report 2015 , 2015 .